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Abstract
Background: Total laryngectomy (TL) is an appropriate oncologic operation for many patients with laryngeal cancer
delivering excellent oncologic outcomes, however it remains beset with significant functional consequences. Following
TL, the upper and lower airways are permanently disconnected, which causes unfiltered, cold air with reduced humidity
to enter the tracheobronchial tree, resulting in mucus overproduction and an increase in the viscosity of the mucus. In
response to this, Heat and moisture exchangers were developed to compensate for the lost functions of the upper
respiratory tract and their effect on the patients’ respiratory performance in addition to their quality of life.
Methods: The case records of 48 patients undergoing total laryngectomy were reviewed and data concerning
demographics, surgical details, post-operative care requirements and adverse events was retrieved. Post hoc analysis
of the case patients was undertaken to identify any benefit of using a heat and moisture exchanger (HME) system with
particular reference to post-operative respiratory outcomes.
Results: There was no significant difference between case and control subjects based on demographics, extent of
surgery or need for flap repair. 16 patients had used a HME and 32 patients had used external humidification (EH). Of
those experiencing mucous plugging, only 3/24 (12.5 %) had used a HME system, in contrast to 21/24 (87.5 %) who used
EH (Chi square = 9.375, p = 0.002). The odds ratio of having an adverse event if not using HME was 8.27 (CI = 1.94 – 35.71).
Use of HME also significantly reduced the number of days requiring physiotherapy (1.75 days vs. 3.20 days, p = 0.034).
Conclusion: Use of an HME system can reduce in-hospital complications, in particular episodes of mucus plugging, and
post-operative care requirements. Furthermore, there is a cost benefit to using HME systems that warrants more
widespread introduction of these devices in head and neck surgery centers.
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Background
Total laryngectomy (TL) is an appropriate oncologic oper-
ation for many patients with laryngeal cancer delivering
excellent oncologic outcomes, however it remains beset
with significant functional consequences. Following TL, the
upper and lower airways are permanently disconnected and
a cervical tracheostoma is created. Whilst this has marked
psychosocial consequences for the laryngectomee patient, it
also presents a significant physiological challenge to their
tracheobronchial tree. The upper airway is responsible for
warming, humidifying and filtering the inspired air before it
reaches the lower airway. The presence of unfiltered, cold
air with reduced humidity causes the tracheobronchial tree
mucosa to dry out. This results in mucus overproduction
and an increase in the viscosity of the mucus. The combin-
ation of these two ultimately lead to mucus plugs and
crusts to form, deleteriously affecting mucociliary clearance
[1]. Furthermore, tracheobronchial irritation produces
metaplasia of the tracheal epithelium. The clinical conse-
quences of this are excessive sputum production, frequent
involuntary coughing and repeated forced expectoration to
clear the airway, negatively impacting the patient’s quality
of life [2].
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Heat and moisture exchangers (HME) were introduced
almost 30 years ago as a means to compensate for the lost
functions of the upper respiratory tract. Additionally, their
effect on the patients respiratory performance and their
quality of life in the long-term have been well documented
[3]. Moreover, it has been noted that it takes at least six
weeks to see improvements in pulmonary status and speech
outcomes [4, 5]. However even in the post-operative period,
the use of HME devices has proven to be effective in im-
proving compliance with humidification delivery, reducing
coughing and forced expectoration as well as improving
sleeping and patient satisfaction [6]. Nonetheless, the im-
pact of HME devices on significant adverse events in the
immediate post-operative period has not previously been
reported. We hypothesized that improved compliance with
humidification by way of HME usage could reduce the
need for escalation of respiratory care and prevent signifi-
cant adverse events such as the management of mucus
plugging. This study aimed to compare total laryngectomy
patients who experienced adverse events (mucus plugging)
with those who did not, and asses if the proportion of
patients who used HME differed between these groups and
contributed to improved clinical outcomes.
Methods
Study design
The Institutional Review Board of the Sunnybrook Health
Sciences Centre approved this study (221–2015). A case–
control study of consecutive total laryngectomy patients
was undertaken to document cases of post-operative com-
plications of mucus plugging, during the patient’s hospital
stay and to identify whether or not the use of HME influ-
enced these occurrences. Analysis on the balance of 1)
previous radiation exposure to the larynx and 2) presence
of pre-existing respiratory conditions (COPD or Asthma),
in the case and control groups, was conducted to ensure
that observed results could not be attributed to these po-
tential confounding factors. Subsequently, if a significant
difference in HME use existed between these groups,
post-hoc analysis will be utilized to identify if patients
using HME had improved clinical outcomes in respect to
their post-operative care requirements and their respira-
tory outcome.
Data acquisition
All Patients who underwent total laryngectomy at Sun-
nybrook Health Sciences Centre by one of two attending
surgeons (KH, DE) were included in the study. Data was
collected by a single reviewer (RDS) and patients were
assigned to the case group if they experienced post-
operative adverse events (mucous plugging). All other pa-
tients were placed into the control group. Demographic
data (age, gender) and surgical data (extent of pharyngect-
omy, use of flap closure, type of flap closure) were obtained
from the case records. Furthermore, details of the post-
operative course including days in ICU, days on the general
ward, frequency of suctioning, frequency of stoma care,
number of days requiring suctioning and number of days
chest physiotherapy was received (either physiotherapist-
led or nurse-led) were recorded. Finally, escalation of treat-
ment indicated by increased humidification requirements,
was recorded. After patients were placed into their respect-
ive groups, the use of, or an absence of an HME device was
established; the cost of using HME for each patient was
collected.
Statistical analysis
Data was collected for the entire course of the patient’s
post-operative course with the clinical endpoint being
hospital discharge. Summary statistics were produced for
the clinical and demographic variables. Case and control
subjects were matched based on gender initially, then on
age (within five years) and finally the need for flap recon-
struction of the pharyngeal defect. Gender matching was
performed first as there were significantly more males in the
study population. Age may reflect physiological performance
and the need for free flap reconstruction indicated the ex-
tent of the operation. All of these factors were considered
significant in predicting adverse outcomes. Matched vari-
ables were compared between the case and control groups
to ensure the variables were balanced. Examination of the
relationship between the case and control groups with the
use of an HME was evaluated using a chi square test. Add-
itionally, chi square analysis was used to assess if there was a
statistically significant difference in the prevalence of con-
founding factors (previous radiation to the larynx or pre-
existing respiratory conditions) across the case and control
groups. Post-hoc analysis, if appropriate, compared patients
who used an HME with those who utilized an external
humification apparatus (EH). These patient groups were
compared on their length of hospital stay, days in ICU, fre-
quency of stoma care, days requiring suctioning, days
physiotherapy was conducted, frequency of nurse-led chest
physiotherapy, amount of mucus, sleep quality or need for
escalation of humidification. For all tests, the difference be-
tween the groups was examined via either the chi square
test for categorical variables or t-test for continuous vari-
ables. Where appropriate for small value groups, Fisher’s
exact test was used in place of the chi square test. p < 0.05
was set as the significance level. All statistics were performed
using SPSS V20 (IBM Corp, Armonk, NY).
Description of Care
All patients who had a free flap were monitored for at least
24 h in the ICU and then transferred to the ward when
medically stable. All patients who did not have free flap re-
construction were monitored in a ward-based step-down
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48 patients were enrolled in this study during the re-
cruitment period. The study group included 38 males
and 10 females. The mean age between groups was not
significantly different (case = 65.33 years, SD = 10.89, con-
trol = 61.54 years, SD = 11.60, p = 0.249). Additionally, the
matched variables proved to be balanced between the case
and control group with no statistically significant differ-
ence observed in the distribution of sex (p = 0.724), the
extent of a pharyngectomy (p = 0.283), or type of flap used
in surgery (p = 0.124). Sixteen patients used a Provox
(Atos Medical Inc, West Allis, WI) HME device in the
post-operative period and 32 were managed with EH.
Surgical details
26 patients had total laryngectomy alone, whereas of the
22 patients who also had pharyngeal resection, 19 had a
partial pharyngectomy and 3 had a total laryngopharyn-
gectomy. This was not statistically different between
groups (p = 0.283). Flap reconstruction was required in 31
patients. The range of flaps used included radial forearm
free flap (n = 3), anterolateral thigh free flap (n = 14),
temporoparietal fascial flap (n = 11), pectoralis major flap
(n = 2) and sternocleidomastoid flap (n = 1). Again there
was no difference between the case and control groups
(p = 0.124).
Adverse events
In this study adverse events were defined as mucus plug-
ging. 24/48 (50 %) experienced mucus plugging in the
post-operative period. Of those experiencing an adverse
event, 3/24 (12.5 %) had used a HME system, in contrast
to 21/24 (87.5 %) who used EH (Fig. 1). There was a sig-
nificant difference between case and control groups
based on use of an HME (Chi square = 9.375, p = 0.002).
The odds ratio (OR) of having an adverse event if not
using HME was 8.27 (CI = 1.94 – 35.71). Additionally,
chi square analysis revealed that there was no statisti-
cally significant difference in prevalence of previous radi-
ation exposure (Table 1) to the larynx between the case
(14/24) and control (11/24) groups (Chi square = 0.751,
p = 0.564). The same conclusion can be made from
examining the prevalence of pre-existing respiratory
conditions (Table 2) between the case (3/24) and control
(4/24) groups (Chi square = 0.167, p = 1). More informa-
tion on the potential confounding variables can be found
in Table 1. Since the total laryngectomy patients with
adverse outcomes had statistically significantly fewer
patients treated with an HME, and there was no statisti-
cally significant relationship in the distribution of the
above potential confounding variables, post-hoc analysis




























Fig. 1 Presence of adverse events based on HME use. Use of HME reduced the chances of an adverse event by an OR of 8.27. Of the 24 patients
with an adverse event, 3 used an HME and 21 used EH. However 13 of 24 patients without an adverse event used an HME, and 11 did not
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was warranted. The results from this are reported in the
sections below.
Post-operative care outcomes
Patients using HME had a non-significant reduction in
their length of hospital stay (17.5 days, SD = 12.90 vs.
22.11 days, SD =20.56; p = 0.418) and fewer days in the in-
tensive care unit (1.53 days, SD = 1.28 vs. 1.67, SD = 2.76;
p = 0.848). There was no difference between the daily
frequencies of stoma care requirements (2.34 episodes,
SD = 0.63 vs. 2.30, SD = 0.51; p = 0.781). These post-
operative care outcomes are also listed in Table 3.
Respiratory outcomes
The HME group had a non-significant reduction in cu-
mulative days of suctioning (9.81 days, SD = 5.05 vs.
10.09, SD = 8.30; p = 0.902). However, there was a signifi-
cant reduction in the days requiring chest physiotherapy
in the HME user group (1.75 days, SD =1.24 vs. 3.20 days,
SD = 0.59; p = 0.034). There was no significant difference
between groups based on frequency of nurse-led chest
physiotherapy, amount of mucus, sleep quality or need for
escalation of humidification. These respiratory outcomes
are listed in Table 3.
Cost analysis
The cost of a single HME cassette is C$3.13. The patients
used a mean of 28.9 cassettes (SD = 11.77) during their hos-
pital stay producing a mean in-hospital cost of C$90.51
(SD =C$36.85) for the device itself.
Discussion
Respiratory function following TL is a significant problem
for both patients and surgeons that represents an area of
ongoing investigation in order to try to optimize outcomes
in this set of patients. The physiological insult that results
from TL can have a devastating effect on the lower respira-
tory tract, which is unaccustomed to the cold, dry, and
unfiltered air that it is presented with following disconnec-
tion of the upper and lower airways. The increase in mucus
production and viscosity along with secondary dysfunction
of the mucociliary elevator reveals itself clinically as fre-
quent, involuntary coughing, excess sputum production
and repeated forced expectoration to try to clear the air-
ways [2, 7]. All of these affect the patient’s quality of life
and ability to return to his or hers pre-operative level of
functioning following TL. These symptoms typically in-
crease over a period of six to twelve months before stabiliz-
ing thereafter. It is important to remember that the majority
of patients undergoing TL for laryngeal cancers are current
or reformed cigarette smokers and therefore are likely to
have a degree of concomitant lower airway disease. In the
context of the aforementioned respiratory consequences of
TL, it becomes clear that this operation can readily aggra-
vate an already precarious functional state [8].
Humidification following TL has traditionally been pro-
vided by way of an external humidification (EH) device
where an electrical heater is connected to an air-driven
evaporator that directly applies moisturized and warmed
air to a mask over the cervical tracheostoma [6]. These
systems are noisy, which impacts sleep, and confine the
patient to the bed or close by to the EH. The HME device
was developed as an alternative to EH that could provide
the same, or better, humidification, warming and filtration
to the inspired air via a body-worn device. This enables
the patient to mobilize normally and also removes the EH
unit from their room. The expired air moisturizes the
HME filter, which then warms and filters particles during
inspiration. An additional benefit is the slight increase in
pulmonary resistance, which can provide a positive end
expiratory pressure to splint the distal airways open [2].
This final function does take some adjustment on the part
of the patient. Patient compliance has been proven to be
essential to the long-term benefits of HME use [8, 9]. The
early adoption of HME in the early post-operative period
enables the patient to become immediately accustomed to
the increased airway resistance the device provides rather
than attempting to adapt to this at a later date.
Whilst the long-term efficacy of HME systems has been
extensively reported, this study is the first to report a reduc-
tion in significant in-hospital adverse events. Whilst much
focus of HME research has been in detailing the long-term
efficacy, our study highlights the potential benefit of HME
systems in minimizing respiratory decompensation early in
Table 1 Prevalence of Previous Radiation to the Larynx
Case Control
Proportion who received radiation 14 of 24 11 of 24
Average Dosage 46.9 Gy 58.4 Gy
Range 8 Gy–70 Gy 20 Gy–70 Gy
Table 2 Prevalence of Pre-existing respiratory conditions
Type of Respiratory Condition Case Control
Number of patients with COPD 3 2
Number of Patients with Asthma 0 2
Table 3 Clinical outcomes for HME vs. EH
Variable Mean HME Mean EH P Value
Days in Hospital 17.5 (SD = 12.90) 22.11 (SD = 20.56) 0.418
Days in ICU 1.53 (SD = 1.28) 1.67 (SD = 2.79) 0.848
Suctioning Per Day 2.47 (SD = 1.07) 2.30 (SD = 0.94) 0.572
Frequency of Stoma Care
(times cleaned per day)
2.34 (SD = 0.63) 2.30 (SD = 0.51) 0.781
Days Requiring Suction 9.81 (SD = 5.05) 10.09 (SD = 8.30) 0.902
Days of PT 1.75 (SD = 0.31) 3.20 (SD = 0.59) 0.034
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the post-operative period. Therefore, in addition to the
established benefit of helping the patient adjust to the in-
creased airway resistance provided by a HME, we propose
that early adoption of HME devices can reduce the inci-
dence of in-hospital adverse events, which has significant
implications for the patient, surgeon and hospital.
HME devices were originally designed in Europe and
much of the current literature pertains to their use on that
continent where they have become an accepted standard
of care. The adoption of HME in North America is only
relatively recent and we believe, whilst other HME devices
have been used, this is the first published series to report
the introduction of the Provox HME devices into head
and neck surgery practice in Canada [10]. Given the dem-
onstrated short and long-term benefits of the HME, the
cost is relatively low. Whilst direct comparison between
EH and HME was not possible due to the retrospective
nature of the data collection, cost data was collected
prospectively for the patients who used an HME device.
The mean in-hospital cost of using an HME was $90.51
(SD = $36.85) for the device itself. The patients using the
device had a range of 9–21 days spent in the hospital, each
using 1–3 HME cassettes a day. Thus, overall, the total
amount of HME cassettes used ranged from 16–47. The
fact that each patient is unique, and thus requires a unique
care plan, resulted in the variation in the amount of HME
devices needed. This explains the large standard deviation
reported for the average price of using the HME device.
Moreover, cost savings are made in terms of number of
disposable suction catheters making introduction of HME
almost cost neutral. The ultimate saving is in patient over-
all morbidity following TL.
Conclusion
HME has well-established long-term efficacy in improving
respiratory outcomes following TL. In the first reported
series from Canada, we have demonstrated that there is a
significant reduction in in-hospital complications with
HME use following TL. Coupled with its well known
long-term benefits the current data supports the more
widespread introduction of these devices in head and neck
surgical practice across Canada and the rest of North
America.
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